The Metabolomic Paradigm of Pharmacogenomics in Complex Disorders

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Metabolomics

• Publication date

  2012-09-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4172/2153-0769.1000E119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Schizophrenia shows a unique metabolomics signature in plasma

  2012cited by this paper
• A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer

  2012cited by this paper
• Translating metabolomics to cardiovascular biomarkers.

  2012cited by this paper
• Obesity and psychotic disorders: uncovering common mechanisms through metabolomics

  2012cited by this paper
• Metabolomics as a Key Integrator for “Omic” Advancement of Personalized Medicine and Future Therapies

  2012cited by this paper
• Pharmacogenomics of Central Nervous System (CNS) Drugs

  2012cited by this paper
• Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics

  2012cited by this paper
• Genomics and pharmacogenomics of brain disorders.

  2012cited by this paper
• Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment

  2012cited by this paper
• ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.

  2011cited by this paper
• Pharmacogenomics of Alzheimer’s Disease

  2011cited by this paper
• Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.

  2011cited by this paper
• Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants

  2010cited by this paper
• Pharmacogenomics and therapeutic strategies for dementia

  2009cited by this paper

• Hepatic Cytochrome P450 Enzymatic System Interaction With Platelet Function and Cardiovascular Outcomes—Pharmacogenomic Impact on Inter‐Organ Communication

  2025cites this paper
• STRUCTURAL POLYMORPHISM OF CYP2D6 AND CYP2C19 GENES MODIFIES THE EFFICACY AND TOXICITY OF PHARMACOTHERAPY FOR DEPRESSIVE STATES

  2024cites this paper
• CONTROL OF THE PHARMACOGENETICS OF ENZYMES’ MEDICINE BIOTRANSFORMATION – A TOOL FOR PROVIDING PERSONALIZED MEDICINE

  2023cites this paper
• Distribution of Polymorphisms of Drug-Related Gene Loci in Hypertension

  2023cites this paper
• Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives

  2022cites this paper
• Management of Hypertension in the Elderly and Frail Patient

  2022cites this paper
• The effect of loss-of-function allele (CYP2C19*3) with Clopidogrel efficacy in coronary heart disease patients

  2021cites this paper
• Farmacogenética en el cáncer de mama: implicaciones de los genes del citocromo p450 en la supervivencia libre de la enfermedad en las mujeres jóvenes

  2021cites this paper
• Pharmacogenomics of Hypertension Treatment

  2020cites this paper
• Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists

  2020cites this paper
• Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders

  2019cites this paper
• Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders

  2019cites this paper
• Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine

  2018influential citation
• Pharmacogenetics of Neurodegenerative Disorders

  2017cites this paper
• Optimization of Antidepressant use with Pharmacogenetic Strategies

  2017cites this paper
• Gene Interactions in the Pharmacogenomics of Alzheimer’s Disease

  2016cites this paper
• Epigenetics of Brain Disorders: The Paradigm of Alzheimers Disease

  2016cites this paper
• Impact of Genomic Medicine on the Future of Neuropsychopharmacology

  2016cites this paper
• Pharmacogenomics of Antidepressant Drugs

  2016cites this paper
• New Insights into the Pathogenesis and Pharmacogenomics of Attention Deficit Hyperactivity Disorder

  2015cites this paper
• Preventive and Predictive Genetics: Towards Personalised Medicine

  2015influential citation
• Pharmacogenomics and its Implementations

  2015cites this paper
• Pharmacoepigenomics and the Metabolomics of Drug Efficacy and Safety

  2015cites this paper
• Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response

  2015cites this paper
• Epigenetic drug discovery for Alzheimer’s disease

  2014cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to Pharmacogenomics

  2014cites this paper
• Benefits of Pharmacogenetics in the Management of Hypertension

  2014cites this paper
• Personalized Medicine of Alzheimer’s Disease

  2014cites this paper
• HSOA Journal of Psychiatry, Depression & Anxiety

  year unknowncites this paper